APAC Over-the-Counter CGM Market Industry Trends and Forecast to 2034: Segmented by (Product, User, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
APAC · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$49.0 MnPlaceholder estimate
Estimate 2025$66.7 Mn24.4% of the global market
Projected 2034$1.07 Bn 1,502.2%Adds $1.00 Bn over 9 forecast years
CAGR 2025–203436.1%Faster than 100% of 173 Medical Devices markets here
Key players5
APAC is 24.39% of the global market.
Among regions, the largest is North America at $123.9 Mn.
Dexcom, Inc., Abbott Laboratories, Levels Health, Nutrisense, Signos (see all)
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The APAC Over-the-Counter CGM Market Analysis Executive Summary
Over-the-counter continuous glucose monitors are sensors sold without a prescription to adults who want to see how food and activity affect their blood sugar.
Key segments of the over-the-Counter CGM market include product (Biosensors and Mobile Apps and Subscriptions) and user (Non-Insulin Type 2 Diabetes, Prediabetes and Wellness Users).
Asia Pacific Over-the-Counter CGM market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
APAC Over-the-Counter CGM Market Dynamics
Market Growth Drivers
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the over-the-Counter CGM market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.
Opportunity
Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the over-the-Counter CGM market, especially in fast-growing emerging economies.
Market Restraints
High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the over-the-Counter CGM market. Long-term safety data and lifestyle support are still needed for many patients.
Competitive Landscape for Over-the-Counter CGM Market in APAC
The over-the-Counter CGM market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Over-the-Counter CGM Market in APAC
Over-the-Counter CGM in APAC: rules and payment
In some of the countries we cover here, medical devices are regulated by TGA (Australia)[1], NMPA (China)[2], MDACS (Hong Kong)[3], CDSCO (India)[4], PMDA (Japan)[5], MDA (Malaysia)[6], Medsafe (WAND) (New Zealand)[7], FDA Philippines (Philippines)[8], HSA (Singapore)[9] and Thai FDA (Thailand)[10]. How care is paid for in some of these countries: Medicare and the PBS (Australia)[11], basic medical insurance (China)[12], the Hospital Authority (Hong Kong)[13], Ayushman Bharat PM-JAY (India)[14], public health insurance (Japan)[15], subsidised public care (Malaysia)[16], Pharmac (New Zealand)[17], PhilHealth (Philippines)[18], MediShield Life (Singapore)[19] and the Universal Coverage Scheme (Thailand)[20].
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how over-the-Counter CGM products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Product
4.2 By User
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Dexcom
7.2 Abbott Laboratories
7.3 Levels Health
7.4 Nutrisense
7.5 Signos
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The over-the-Counter CGM market can be segmented based on various criteria, including product, user and end user. Here's a breakdown of the market segmentation
What doctors and scientists are doing in Over-the-Counter CGM right now, from free public sources.
Clinical trials
93 active trials in China, India, Japan, Australia, Hong Kong, Philippines, Singapore, Thailand, Malaysia, New Zealand, Bangladesh, Afghanistan, Indonesia, Myanmar, Nepal and Pakistan
Recruiting, about to start, or running now. Counted across the 16 countries we report on in APAC.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
WHO Global Health Observatory.
Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
How big is the Over-the-Counter CGM market in Asia Pacific?
Placeholder estimate: about $66.7 Mn in 2025, rising to about $1.07 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Over-the-Counter CGM market in Asia Pacific growing?
Placeholder estimate: about 36.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Over-the-Counter CGM market report cover?
The report splits the market by product (Biosensors, Mobile Apps and Subscriptions), user (Non-Insulin Type 2 Diabetes, Prediabetes, Wellness Users) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Over-the-Counter CGM market?
Key players include Dexcom, Inc., Abbott Laboratories, Levels Health, Nutrisense and Signos.
What is driving the Over-the-Counter CGM market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the over-the-Counter CGM market.